▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Dan Carroll

TMFCane

Dan began writing for the Motley Fool in 2012. He is a health care specialist who also follows the defense industry along with tracking the broader U.S. and international markets.

Recent Articles by Dan Carroll

Jun 16, 2014 by Dan Carroll

Chevron, Home Depot Jump Despite a Sluggish Dow

Medtronic makes huge news off the Dow with its surprising buy of Covidien.

Jun 15, 2014 by Dan Carroll

Forget Obamacare Exchanges: This Is the Real Healthcare Revolution

Accountable Care Organizations may not be the Affordable Care Act's buzzword, but this shift in how insurers, hospitals, doctors, and patients approach health care could transform this sector - and make smart investors rich.

Jun 13, 2014 by Dan Carroll

The 3 Best Health Insurance Stocks of 2014

Obamacare has helped insurance stocks rise this year, but these three stocks have jumped ahead of the competition.

Jun 13, 2014 by Dan Carroll

The 3 Best Big Pharma Dividend Stocks of the Past 10 Years

Big pharma's been in a funk over the recent past with the patent cliff and the recession, but these three stocks have delivered for investors.

Jun 13, 2014 by Dan Carroll

Intel, Microsoft Keep the Dow in the Green

Intel rockets up after a big increase in its outlook, but investors need to keep an eye on the long term.

Jun 12, 2014 by Dan Carroll

Caterpillar Grinds its Gears as the Dow Loses 100 Points

Airline stocks take a big hit as fuel prices spike behind Iraqi instability.

Jun 11, 2014 by Dan Carroll

Is Medtronic's Dividend Safe?

Medtronic has risen to become a top dividend stock in the medical device industry, but can you count on this yield for the long term?

Jun 11, 2014 by Dan Carroll

Boeing Falls Back to Earth as the Dow Plunges 100 Points

A downbeat look at global growth from the World Bank has Wall Street pulling back from the market's recent record highs.

Jun 10, 2014 by Dan Carroll

IBM Powers Down the Dow Despite Intel's Gain

A downbeat day for investors sees Allergan once again spurning Valeant Pharmaceuticals' takeover bid.

Jun 9, 2014 by Dan Carroll

Merck's Huge Hep C Buy Shakes Up the Dow

Tyson Foods makes the other big acquisition of the day, snapping up Hillshire Brands.

Jun 6, 2014 by Dan Carroll

DAX 10,000: Is Europe's Biggest Market Still Its Biggest Opportunity?

Germany's lead stock index hit a record high, but there's plenty to like for the country's top exporters -- and their investors -- in the future.

Jun 6, 2014 by Dan Carroll

Pfizer Falls, but the Dow's Record Run Continues

Hertz falls sharply on an accounting error that could alter the company's 2011 results.

Jun 6, 2014 by Dan Carroll

Should Medtronic Buy Smith & Nephew?

Medtronic's avoided rumors of takeover interest, but should the market's largest pure medical device player make a big push into orthopedics?

Jun 5, 2014 by Dan Carroll

Why Smith & Nephew, Rite Aid, and Zynga Are Today's 3 Worst Stocks

Zynga continues its disappointing streak of the past three months on a day when most of the market celebrated a record-high close

Jun 5, 2014 by Dan Carroll

Caterpillar's Buildup Leads the Dow's Record Close

Aggressive moves from Europe lead off a strong day for Dow investors.

Jun 5, 2014 by Dan Carroll

Europe's Push for a Recovery Lifts the Dow to Intraday High

The European Central Bank slashes its benchmark and pushes a negative deposit rate in an attempt to jump-start the continent's sluggish economic growth.

Jun 4, 2014 by Dan Carroll

Boeing Hits a Snag as the Dow Fights Off a Loss

The Dow Jones rebounds from an earlier drop, while Under Armour is today's big winner outside the blue-chip index.

May 30, 2014 by Dan Carroll

Should Johnson & Johnson Join the Buyout Boom?

J&J's shied away from health care's blockbuster acquisitions race so far in 2014, but with Stryker denying interest in buying Smith & Nephew, this orthopedics giant could make a huge splash in medical devices.

May 30, 2014 by Dan Carroll

Caterpillar Grinds Its Gears on a Sluggish Day for the Dow

Wal-Mart edges higher, but stocks end the week on a modest note.

May 29, 2014 by Dan Carroll

Merck's Stock Tops the Dow as Tyson Makes a Bold Bet for Hillshire Brands

Tyson Foods makes the biggest market-shaking news of the day with a $50 per share offer for Hillshire Brands.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services